The let-7 microRNA binding site variant in KRAS as a predictive biomarker for head and neck cancer patients with

Murat Ulusan1, Sena Sen2, Rasim Yilmazer1

  • 1Department of Otorhinolaryngology-Head and Neck Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.

Abstract

Insights

The KRAS-LCS6 variant, a let-7 miRNA binding site polymorphism, is not linked to head and neck cancer (HNC) risk. However, this variant may predict lymph node metastasis in HNC patients.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • The let-7 miRNA family regulates oncogenes like KRAS, impacting carcinogenesis.
  • Polymorphic variations in miRNA binding sites can influence cancer development and progression.

Purpose of the Study:

  • To investigate the KRAS-LCS6 variant (rs61764370) in the 3'UTR of the KRAS gene.
  • To assess its potential as a predictive biomarker for head and neck cancer (HNC).
  • To evaluate associations between the KRAS-LCS6 variant and HNC clinicopathological parameters.

Main Methods:

  • Genotyping of the KRAS-LCS6 variant in 216 Turkish HNC patients and 85 healthy controls.
  • DNA extraction from whole blood followed by polymerase chain reaction and restriction fragment length polymorphism analysis.
  • Evaluation of genotype and allele frequencies using De-Finetti case-control program and univariate/Cox regression analyses.

Main Results:

  • The KRAS-LCS6 variant was not associated with overall HNC risk (p > 0.05).
  • The homozygous variant allele showed a significant association with lymph node metastasis in HNC patients (OR=2.370, p=0.03).
  • Genotype frequencies were significantly associated with gender, smoking status, alcohol consumption, disease stage, and lymph node metastasis (p < 0.05).

Conclusions:

  • This study is the first to demonstrate a link between the KRAS-LCS6 variant and lymph node metastasis in HNC.
  • The KRAS-LCS6 variant may serve as a potential predictive biomarker for lymph node metastasis in head and neck cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.8K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.4K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.7K